AUPH
Price
$8.19
Change
+$0.10 (+1.24%)
Updated
Jun 6 closing price
Capitalization
1.09B
53 days until earnings call
CRDF
Price
$3.88
Change
+$0.26 (+7.18%)
Updated
Jun 6 closing price
Capitalization
240.49M
53 days until earnings call
Interact to see
Advertisement

AUPH vs CRDF

Header iconAUPH vs CRDF Comparison
Open Charts AUPH vs CRDFBanner chart's image
Aurinia Pharmaceuticals
Price$8.19
Change+$0.10 (+1.24%)
Volume$911.77K
Capitalization1.09B
Cardiff Oncology
Price$3.88
Change+$0.26 (+7.18%)
Volume$1.15M
Capitalization240.49M
AUPH vs CRDF Comparison Chart
Loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUPH vs. CRDF commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUPH is a StrongBuy and CRDF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (AUPH: $7.98 vs. CRDF: $3.19)
Brand notoriety: AUPH and CRDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUPH: 87% vs. CRDF: 62%
Market capitalization -- AUPH: $1.09B vs. CRDF: $240.49M
AUPH [@Biotechnology] is valued at $1.09B. CRDF’s [@Biotechnology] market capitalization is $240.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUPH’s FA Score shows that 0 FA rating(s) are green whileCRDF’s FA Score has 0 green FA rating(s).

  • AUPH’s FA Score: 0 green, 5 red.
  • CRDF’s FA Score: 0 green, 5 red.
According to our system of comparison, AUPH is a better buy in the long-term than CRDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUPH’s TA Score shows that 5 TA indicator(s) are bullish while CRDF’s TA Score has 3 bullish TA indicator(s).

  • AUPH’s TA Score: 5 bullish, 4 bearish.
  • CRDF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AUPH is a better buy in the short-term than CRDF.

Price Growth

AUPH (@Biotechnology) experienced а -4.32% price change this week, while CRDF (@Biotechnology) price change was +10.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

AUPH is expected to report earnings on Jul 31, 2025.

CRDF is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUPH($1.09B) has a higher market cap than CRDF($240M). AUPH YTD gains are higher at: -11.136 vs. CRDF (-26.498). AUPH has higher annual earnings (EBITDA): 31.7M vs. CRDF (-48.25M). AUPH has more cash in the bank: 358M vs. CRDF (91.7M). CRDF has less debt than AUPH: CRDF (1.52M) vs AUPH (79.4M). AUPH has higher revenues than CRDF: AUPH (235M) vs CRDF (683K).
AUPHCRDFAUPH / CRDF
Capitalization1.09B240M455%
EBITDA31.7M-48.25M-66%
Gain YTD-11.136-26.49842%
P/E Ratio29.94N/A-
Revenue235M683K34,407%
Total Cash358M91.7M390%
Total Debt79.4M1.52M5,213%
FUNDAMENTALS RATINGS
AUPH vs CRDF: Fundamental Ratings
AUPH
CRDF
OUTLOOK RATING
1..100
1415
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
10089
SMR RATING
1..100
8997
PRICE GROWTH RATING
1..100
4858
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRDF's Valuation (66) in the null industry is in the same range as AUPH (67) in the Biotechnology industry. This means that CRDF’s stock grew similarly to AUPH’s over the last 12 months.

CRDF's Profit vs Risk Rating (89) in the null industry is in the same range as AUPH (100) in the Biotechnology industry. This means that CRDF’s stock grew similarly to AUPH’s over the last 12 months.

AUPH's SMR Rating (89) in the Biotechnology industry is in the same range as CRDF (97) in the null industry. This means that AUPH’s stock grew similarly to CRDF’s over the last 12 months.

AUPH's Price Growth Rating (48) in the Biotechnology industry is in the same range as CRDF (58) in the null industry. This means that AUPH’s stock grew similarly to CRDF’s over the last 12 months.

AUPH's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CRDF (100) in the null industry. This means that AUPH’s stock grew similarly to CRDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AUPHCRDF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
76%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
84%
MACD
ODDS (%)
Bearish Trend 11 days ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
79%
Bullish Trend 11 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
84%
Bullish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 11 days ago
87%
Declines
ODDS (%)
Bearish Trend about 1 month ago
84%
Bearish Trend 17 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
90%
Bearish Trend 11 days ago
86%
Aroon
ODDS (%)
Bullish Trend 11 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

AUPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with CMRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUPH
1D Price
Change %
AUPH100%
-2.09%
CMRX - AUPH
38%
Loosely correlated
N/A
SHJBF - AUPH
38%
Loosely correlated
N/A
KRYS - AUPH
37%
Loosely correlated
-2.44%
CRDF - AUPH
37%
Loosely correlated
+2.90%
SCPH - AUPH
36%
Loosely correlated
+1.13%
More

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with CMRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then CMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
+2.90%
CMRX - CRDF
45%
Loosely correlated
N/A
ABSI - CRDF
42%
Loosely correlated
+0.74%
MRVI - CRDF
42%
Loosely correlated
-0.90%
BEAM - CRDF
40%
Loosely correlated
-0.88%
NAMS - CRDF
39%
Loosely correlated
+1.76%
More